Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 232Carcinoma, Non-Small-Cell Lung 229Prostatic Neoplasms 168Multiple Myeloma 155Neoplasms 132Colorectal Neoplasms 123Leukemia, Myeloid, Acute 122Lung Neoplasms 112Neoplasm Metastasis 101Squamous Cell Carcinoma of Head and Neck 91Carcinoma, Hepatocellular 90Melanoma 87Lymphoma 84Triple Negative Breast Neoplasms 76Pancreatic Neoplasms 75Ovarian Neoplasms 71Sarcoma 67Lymphoma, Large B-Cell, Diffuse 66Carcinoma, Renal Cell 64Brain Neoplasms 63Recurrence 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Head and Neck Neoplasms 57Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, Non-Hodgkin 53Urinary Bladder Neoplasms 52Stomach Neoplasms 52Hematologic Neoplasms 52Rectal Neoplasms 49Small Cell Lung Carcinoma 48

Interventions

obeticholic acid 1Specimen Handling 1Endoscopy, Gastrointestinal 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Duodenal Neoplasms × 90 days × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡